These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
632 related articles for article (PubMed ID: 25510273)
1. Novel immunotherapies for hematologic malignancies. Nelson MH; Paulos CM Immunol Rev; 2015 Jan; 263(1):90-105. PubMed ID: 25510273 [TBL] [Abstract][Full Text] [Related]
2. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy. Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapeutic approaches for hematologic malignancies. Caligiuri MA; Velardi A; Scheinberg DA; Borrello IM Hematology Am Soc Hematol Educ Program; 2004; ():337-53. PubMed ID: 15561691 [TBL] [Abstract][Full Text] [Related]
4. T-cell-based Immunotherapies for Haematological Cancers, Part A: A SWOT Analysis of Immune Checkpoint Inhibitors (ICIs) and Bispecific T-Cell Engagers (BiTEs). Rallis KS; Hillyar CRT; Sideris M; Davies JK Anticancer Res; 2021 Mar; 41(3):1123-1141. PubMed ID: 33788704 [TBL] [Abstract][Full Text] [Related]
5. Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies. Ye B; Stary CM; Gao Q; Wang Q; Zeng Z; Jian Z; Gu L; Xiong X J Immunol Res; 2017; 2017():5210459. PubMed ID: 28116322 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy in hematologic malignancies: past, present, and future. Im A; Pavletic SZ J Hematol Oncol; 2017 Apr; 10(1):94. PubMed ID: 28434396 [TBL] [Abstract][Full Text] [Related]
7. Chimeric antigen receptor T-cell therapy to target hematologic malignancies. Kenderian SS; Ruella M; Gill S; Kalos M Cancer Res; 2014 Nov; 74(22):6383-9. PubMed ID: 25371415 [TBL] [Abstract][Full Text] [Related]
8. The expanding horizon of immunotherapy in the treatment of malignant disorders: allogeneic hematopoietic stem cell transplantation and beyond. Tsirigotis P; Shimoni A; Nagler A Ann Med; 2014 Sep; 46(6):384-96. PubMed ID: 24888385 [TBL] [Abstract][Full Text] [Related]